Clinical Manifestations and Outcomes of Patients with Sarcomatoid Hepatocellular Carcinoma

Hepatology ◽  
2019 ◽  
Vol 69 (1) ◽  
pp. 209-221 ◽  
Author(s):  
Sih-Han Liao ◽  
Tung-Hung Su ◽  
Yung-Ming Jeng ◽  
Po-Chin Liang ◽  
Ding-Shinn Chen ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Clinical Manifestations

Clinical manifestations and outcomes of patients with scirrhous hepatocellular carcinoma

2021 ◽  
Author(s):  
Shang-Chin Huang ◽  
Sih-Han Liao ◽  
Tung-Hung Su ◽  
Yung-Ming Jeng ◽  
Jia-Horng Kao
Keyword(s):  
Hepatocellular Carcinoma ◽  
Clinical Manifestations

Clinical manifestations and survival of patients with hepatocellular carcinoma and cardiac metastasis

2010 ◽  
Vol 25 (1) ◽  
pp. 150-155 ◽  
Author(s):  
Yu-Chun Liu ◽  
Yi-Lwun Ho ◽  
Guan-Tarn Huang ◽  
Ding-Shinn Chen ◽  
Jin-Chuan Sheu ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Clinical Manifestations ◽  
Cardiac Metastasis

scholarly journals Hepatoid Adenocarcinoma of the Stomach: Current Perspectives and New Developments

2021 ◽  
Vol 11 ◽  
Author(s):  
Ruolan Xia ◽  
Yuwen Zhou ◽  
Yuqing Wang ◽  
Jiaming Yuan ◽  
Xuelei Ma
Keyword(s):  
Gastric Cancer ◽  
Hepatocellular Carcinoma ◽  
Malignant Tumor ◽  
Advanced Disease ◽  
Clinical Manifestations ◽  
Disease Stage ◽  
Hepatoid Adenocarcinoma ◽  
New Developments ◽  
Advanced Disease Stage ◽  
Worse Prognosis

Hepatoid adenocarcinoma of the stomach (HAS) is a rare malignant tumor, accounting for only 0.17–15% of gastric cancers. Patients are often diagnosed at an advanced disease stage, and their symptoms are similar to conventional gastric cancer (CGC) without specific clinical manifestation. Morphologically, HAC has identical morphology and immunophenotype compared to hepatocellular carcinoma (HCC). This is considered to be an underestimation in diagnosis due to its rare incidence, and no consensus is reached regarding therapy. HAS generally presents with more aggressive behavior and worse prognosis than CGC. The present review summarizes the current literature and relevant knowledge to elaborate on the epidemic, potential mechanisms, clinical manifestations, diagnosis, management, and prognosis to help clinicians accurately diagnose and treat this malignant tumor.

Hepatocellular carcinoma of diffuse type: MR imaging findings and clinical manifestations

2003 ◽  
Vol 18 (2) ◽  
pp. 189-195 ◽  
Author(s):  
Masayuki Kanematsu ◽  
Richard C. Semelka ◽  
Polytimi Leonardou ◽  
Maria Mastropasqua ◽  
Joseph K.T. Lee
Keyword(s):  
Hepatocellular Carcinoma ◽  
Mr Imaging ◽  
Clinical Manifestations ◽  
Imaging Findings ◽  
Diffuse Type
Sign in / Sign up

Export Citation Format

Share Document